Obbligazioni
Di seguito è riportato l'elenco delle obbligazioni societarie Bristol-Myers Squibb Company. Gli investitori spesso optano per le obbligazioni di una società per la loro maggiore stabilità in tempi di volatilità del mercato. Studia i prezzi, i rendimenti e altre statistiche per trovare un investimento affidabile.
Simbolo | YTM % | Volume | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
|---|---|---|---|---|---|---|---|---|---|
| BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | 6,95% | 30 K | 82,51% | 5,250% | 2043-08-15 | 4,06 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| 6,30% | 165 K | 99,90% | 0,750% | 2025-11-13 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | 6,19% | 58 K | 82,83% | 4,625% | 2044-05-15 | 3,69 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | 5,97% | 5 K | 80,09% | 4,350% | 2047-11-15 | 13,57 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | 5,79% | 30 K | 99,05% | 5,700% | 2040-10-15 | 2,3 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | 5,78% | 20 K | 84,30% | 4,550% | 2048-02-20 | 37,2 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| 5,74% | 39 K | 119,25% | 6,875% | 2097-08-01 | 62,42 M USD | 1.000,00 USD | 1.000,00 USD | Bristol Myers Squibb Co. | |
| 5,66% | 0 | 73,00% | 3,900% | 2062-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,63% | 0 | 100,28% | 5,650% | 2064-02-22 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,61% | 0 | 99,03% | 5,550% | 2054-02-22 | 2,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,58% | 0 | 112,84% | 6,400% | 2063-11-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,56% | 30 K | 96,50% | 5,250% | 2043-08-15 | 218,37 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,54% | 0 | 74,56% | 3,700% | 2052-03-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | 5,52% | 218 K | 93,74% | 5,000% | 2045-08-15 | 15,71 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| 5,51% | 0 | 60,00% | 2,550% | 2050-11-13 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,51% | 974 K | 87,69% | 4,550% | 2048-02-20 | 1,24 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,51% | 38 K | 83,31% | 4,250% | 2049-10-26 | 3,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,49% | 80 K | 85,55% | 4,350% | 2047-11-15 | 1,24 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,47% | 0 | 88,84% | 4,500% | 2044-03-01 | 341,52 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,45% | 0 | 111,44% | 6,250% | 2053-11-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,45% | 0 | 100,57% | 5,500% | 2044-02-22 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,43% | 1,46 M | 90,68% | 4,625% | 2044-05-15 | 744,72 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,36% | 404 K | 95,63% | 5,000% | 2045-08-15 | 741,72 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,32% | 0 | 80,80% | 3,550% | 2042-03-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,29% | 17 K | 77,46% | 3,250% | 2042-08-01 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,22% | 0 | 70,36% | 2,350% | 2040-11-13 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,12% | 30 K | 105,92% | 5,700% | 2040-10-15 | 151,01 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 5,03% | 200 K | 91,10% | 4,125% | 2039-06-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 4,93% | 726 K | 111,05% | 6,125% | 2038-05-01 | 219,25 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 4,77% | 24 K | 109,37% | 5,875% | 2036-11-15 | 279,22 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 4,72% | 0 | 103,23% | 5,200% | 2034-02-22 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 4,68% | 0 | 100,06% | 4,950% | 2026-02-20 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 4,55% | 0 | 108,99% | 5,900% | 2033-11-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 4,41% | 0 | 91,95% | 2,950% | 2032-03-15 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 4,37% | 0 | 103,40% | 5,100% | 2031-02-22 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 4,31% | 0 | 106,66% | 5,750% | 2031-02-01 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | 4,19% | 20 K | 99,36% | 3,900% | 2028-02-20 | 43,84 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| 4,14% | 0 | 98,86% | 3,250% | 2027-02-27 | 512,28 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 4,12% | 10,09 M | 88,02% | 1,450% | 2030-11-13 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 4,10% | 0 | 102,41% | 4,900% | 2029-02-22 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 4,04% | 0 | 101,07% | 4,900% | 2027-02-22 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 4,03% | 1,71 M | 97,85% | 3,400% | 2029-07-26 | 2,37 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | 3,95% | 10 K | 99,02% | 3,450% | 2027-11-15 | 16,55 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
| 3,94% | 55 K | 99,89% | 3,900% | 2028-02-20 | 1,45 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 3,90% | 20 K | 99,59% | 3,200% | 2026-06-15 | 1,74 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 3,86% | 0 | 94,73% | 1,125% | 2027-11-13 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 3,85% | 50 K | 99,24% | 3,450% | 2027-11-15 | 517,67 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 3,82% | 500 K | 98,50% | 3,400% | 2029-07-26 | 26,56 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 3,71% | 634 K | 103,08% | 6,800% | 2026-11-15 | 255,95 M USD | 1.000,00 USD | 1.000,00 USD | Bristol Myers Squibb Co. | |
| 3,46% | 0 | 86,30% | 1,750% | 2035-05-15 | 575 M EUR | 1.000,00 EUR | 100.000,00 EUR | Bristol Myers Squibb Co. | |
| 2,74% | 0 | 130,24% | 4,250% | 2049-10-26 | 500 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 2,70% | 0 | 141,76% | 5,000% | 2045-08-15 | 1 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 2,62% | 0 | 137,60% | 4,550% | 2048-02-20 | 9,5 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 2,60% | 0 | 122,76% | 4,125% | 2039-06-15 | 4,4 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 2,31% | 0 | 104,25% | 3,200% | 2026-06-15 | 5,95 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 1,57% | 0 | 116,80% | 3,900% | 2028-02-20 | 6,07 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| 1,36% | 0 | 114,77% | 3,450% | 2027-11-15 | 67 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
| — | 3,9 M | 100,10% | 4,772% | 2026-02-20 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |